Related Experiment Video
Updated: Aug 9, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Chronic kidney disease mineral and bone disorder: A guide for general practice
1MBBS (Hons), General and Acute Care Medicine Advanced Physician Trainee, The Alfred Hospital, Melbourne, Vic; Adjunct Lecturer, Central Clinical School, Monash University, Melbourne, Vic.
Insights
General practitioners can screen and manage chronic kidney disease mineral and bone disorder (CKD-MBD) starting in stage 3a CKD. Early intervention improves bone health and reduces cardiovascular risk in CKD patients.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Medicine
Background:
- Chronic kidney disease mineral and bone disorder (CKD-MBD) significantly increases morbidity, cardiovascular risk, and mortality in chronic kidney disease (CKD) patients.
- CKD-MBD manifestations begin as early as stage 3a CKD.
- General practitioners are vital for community-based screening, monitoring, and early management of CKD-MBD.
Approach:
- This article summarizes evidence-based principles for understanding CKD-MBD pathogenesis.
- It details current assessment strategies for CKD-MBD.
- It reviews a spectrum of management approaches for CKD-MBD.
Key Points:
- CKD-MBD encompasses biochemical abnormalities, bone disease, and calcification of soft tissues and vasculature.
- Management focuses on monitoring and controlling biochemical parameters.
- Strategies aim to enhance bone health and mitigate cardiovascular risk.
Conclusions:
- Effective management of CKD-MBD requires a comprehensive approach addressing its multifaceted nature.
- Early detection and intervention by general practitioners are crucial for improving patient outcomes.
- Evidence-based treatments are available to manage CKD-MBD and its associated complications.
Background:
Chronic kidney disease mineral and bone disorder (CKD-MBD) is an important cause of morbidity, cardiovascular risk and mortality among patients with chronic kidney disease (CKD). The condition begins to manifest in stage 3a CKD. General practitioners play a crucial part in screening, monitoring and early management of this important problem, which is primarily managed in the community.
Objective:
The aim of this article is to summarise the key evidence-based principles of the pathogenesis, assessment and management of CKD-MBD.
Discussion:
CKD-MBD includes a spectrum of disease involving biochemical changes, bone abnormalities and vascular and soft tissue calcification. Management is centred on monitoring and controlling biochemical parameters with a variety of strategies to improve bone health and cardiovascular risk. The range of evidence-based treatment options is reviewed in this article.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Urinary Tract Calculi III: Medical Management

